ARCHIVES

ODAC Votes to Nix Amgen’s Drug Xgeva For Proposed Prostate Cancer Indication

This article is from The Cancer Letter archive.

Vol. 38 No. 07 | February 17, 2012

Download PDF Visit The Full Archive

Related Articles

PROPOC Study Analyses Six Cancer DRGs

January 17, 1986

FDA Approves New Device For Glioblastoma Multiforme

April 29, 2011

Doctor-Patient Conversations At End of Life Associated With Lower Medical Expenses

March 27, 2009

NCI Cooperative Group Members To Test Online Registration.

September 8, 2000

Shubik Group Finally Completes Document On Carcinogenicity Criteria

March 12, 1976

NCI To Offer Advice On Unconventional Therapy. Not Funds

December 14, 1990